Home
Abstract
My Abstract(s)
Login
ePosters
Back
Final Presentation Format
Moderated Poster Abstract
Eposter Presentation
Eposter in PDF Format
Accept format: PDF. The file size should not be more than 5MB
Eposter in Image Format
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
Presentation Date / Time
Submission Status
Submitted
Abstract
Abstract Title
Micro/nanomotors in Biomedicine: Construction and Applications
Presentation Type
Moderated Poster Abstract
Manuscript Type
Basic Research
Abstract Category *
Novel Advances: New Technology
Author's Information
Number of Authors (including submitting/presenting author) *
1
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Country
China
Co-author 1
kun Yuan yuankun_cqmu@163.com Huazhong University of Science and Technology Tongji Hospital Wuhan China *
Co-author 2
Co-author 3
Co-author 4
Co-author 5
Co-author 6
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
Co-author 16
Co-author 17
Co-author 18
Co-author 19
Co-author 20
Abstract Content
Introduction
The significant potential for autonomous movement and adaptable modification has made micro/nanomotors a major focus of research and application in biomedicine. However, current designs for micro/nanomotors face several unresolved issues, including improving propulsion methods, precise navigation control, expanding application ranges, ensuring biological safety, and achieving multifunctionality. This review provides a comprehensive overview of recent progress in the application of micro/nanomotors in biomedicine, focusing on propulsion mechanisms, targeting strategies, structural design, and practical applications.
Materials and Methods
In this review, we summarize the latest advancements in the construction and application of Micro/nanomotors (MNMs) and categorize these developments. MNMs have been utilized in various biomedical fields, with their active motility and targeting capabilities revolutionizing in vivo delivery technologies. This transformation has significantly enhanced delivery efficiency and reduced off-target effects. Various therapeutic approaches, such as physical therapy, biological therapy, chemical drug therapy, and immunotherapy, are continuously being developed and implemented. Furthermore, biosensing technologies derived from MNMs have enhanced detection sensitivity and quality. The potential for removing toxic substances from biological systems may also develop in the future. In addition, researchers are integrating MNMs as probes and imaging agents into traditional medical devices, which demonstrates their vast potential. We anticipate the development of multifunctional MNMs tailored to specific application needs, with various propulsion modes being employed.
Results
This review begins by providing an overview of the three major elements of MNMS construction: propulsion, targeting, and structure. We point the current issues associated with these elements and examine the attempted solutions. Our discourse also analyzes the current status and summarizes the development trends in various fields to provide researchers with valuable insights. Additionally, this review outlines the primary applications of MNMs in the biomedical field, discusses the development trends and establishes directions for the advancement of multimode propulsion and multifunctional integration platforms.
Conclusions
MNMs, as a medical device, face complex ethical, moral, and legal issues. The impact of the fabrication and application of MNMs on biological systems lacks real-time and effective regulatory measures, which results in widespread regulatory obstacles. Furthermore, the effects of MNMs upon entering biological organisms have not been thoroughly investigated. This lack makes their long-term safety unconvincing. Regulatory authorities and researchers should enhance the technical and ethical oversight of MNMs, refine existing laws, and conduct further research throughout the entire application process to ensure their transition into clinical practice.
Keywords
Micromotors, Nanomotors, Biomedical applications, Propulsion mechanisms, Tumor therapy
Figure 1
https://storage.unitedwebnetwork.com/files/1237/354442a40e8b07ebf5a9e175d03a48e2.png
Figure 1 Caption
Propulsion mechanisms of nanomotors: redox reaction driven (left), external field driven (middle), synergistic driven (right).
Figure 2
https://storage.unitedwebnetwork.com/files/1237/abf397d887a1df17c4bc1ddc0bae13d2.png
Figure 2 Caption
Bubble propulsion nanomotors. A Synthetic procedure (left) and SEM images (right) for the preparation of Pt@HSN from ref.(1). B Scheme of the fabrication of the Mg@anti-CD3 MNMs from ref.(2). C The schematic diagram illustrating the synthesis(top) an
Figure 3
https://storage.unitedwebnetwork.com/files/1237/08ad3364ebc2b4b4ab610bafc61749c3.png
Figure 3 Caption
The targeted strategy of nanomotors A The Pt/DOX/LOX/LM-cRGD MNMs under lactate gradient exhibits positive chemotaxis in vivo and alleviates hypoxia through cascade catalysis from ref.(6). B Illustration of NIR-guided GNCs Pt-ICG/ Tf nanomotors for s
Figure 4
https://storage.unitedwebnetwork.com/files/1237/f2d73de01562d4b20e126701e4c67a1c.png
Figure 4 Caption
Biohybrids nanomotors. A Efficiency of dual power nanomotors driven by different driving reactions in pressure gradient environments from ref.(9). B Schematic illustration of active targeting and intracellular internalization of mC@SiO2@DOX for enhan
Figure 5
https://storage.unitedwebnetwork.com/files/1237/60f9ca7db5796790ea6f19f423f7699e.png
Figure 5 Caption
The applications of nanomotors in biomedicine: cargo delivery. A Schematic diagram of MIL-88-ICG@ZIF-8-DOX nanomotors synthesis (bottom) and its application in synergistic photothermal/photodynamic/chemotherapy treatment of tumors (top) from ref.(14)
Character Count
2960
Vimeo Link
Presentation Details
Session
Free Paper Moderated Poster(10): Oncology Bladder UTUC (B) & Functional Urology
Date
Aug. 17 (Sun.)
Time
11:48 - 11:52
Presentation Order
18